Clinical Trials on Carcinomas/Neoplasms

Total 107168 results

Herbert H. Lehman College, City University of New...
University of Utah

Terminated

Rhythmic Entrainment in Bilingual Speakers With Dysarthria

Parkinson Disease | Ataxia

United States
Yale University
Tourette Association of America

Terminated

FAAH Inhibitor Trial for Adults With Tourette Syndrome

Tourette Syndrome

United States
University of Zurich
Swiss Federal Institute of Technology

Completed

Mass Spectral Fingerprinting in Obstructive Sleep Apnoea

Obstructive Sleep Apnoea (OSA) | Mass Spectrometry | Exhaled Breath

Switzerland
Lawson Health Research Institute

Unknown

A Comparison of Voice Amplifiers and Personal Communication Systems in Individuals With Parkinson's Disease

Parkinson's Disease | Dysarthria
University Hospital Tuebingen
Michael J. Fox Foundation for Parkinson's Research

Unknown

Combined Stimulation of STN and SNr for Dysphagia in Parkinson's Disease

Parkinson's Disease | Dysphagia

Germany
Stanford University

Withdrawn

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.

Ocular Hypertension | Glaucoma | Thyroid Eye Disease

United States
St. Louis University

Withdrawn

Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Incontinence, Urge | Nocturia | Incontinence, Urinary | Urinary Frequency/Urgency

United States
Guang'anmen Hospital of China Academy of Chinese...

Unknown

The Effect and Safety of Plum-blossom Needle for Tourette Syndrome

Tourette Syndrome

China
Hospices Civils de Lyon

Completed

HPV Vaccination in Women With Cystic Fibrosis (VACCIN-HPV-MUC)

Human Papillomavirus Infection

France
Joslin Diabetes Center
Abbott

Completed

Vitamin D and Coronary Calcification Study (VCOR)

Vitamin D Deficiency | Chronic Kidney Disease | Coronary Calcification | Disorders of Calcium and Bone Metabolism

United States
Baylor College of Medicine
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

Tourette Syndrome
Valen Chia

Completed

Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) (NAION)

Non-arteritic Anterior Ischemic Optic Neuropathy

Indonesia
University of Florida

Completed

Sensory Processing in Tourette Syndrome

Tourette Syndrome

United States
Aurora Health Care

Withdrawn

Inpatient Physical Activity Function Through Enhanced Participation Levels in Animal-Assisted Therapy Programs

Stroke | Parkinson's Disease | Muscle Weakness

United States
Weill Medical College of Cornell University
Hamad Medical Corporation; Weill Cornell Medical College in Qatar

Completed

Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) (Q-BC)

Asthma | Lung Cancer | Cystic Fibrosis | Interstitial Lung Disease | COPD

Qatar
The Cleveland Clinic
University Hospitals Cleveland Medical Center

Completed

Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple Sclerosis

United States
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Parkinson Disease | Impulse Control Disorder

United States
Ophthalmic Consultants of Boston
Regeneron Pharmaceuticals

Completed

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion (ANDROID)

Central Retinal Vein Occlusion | Proliferative Diabetic Retinopathy

United States
Northwestern University
ViraCor Laboratories

Completed

Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

Atopic Dermatitis | Ichthyosis Vulgaris

United States
McGill University Health Centre/Research Institute...

Completed

Treatments for Insomnia in Patients With Parkinson's Disease

Parkinson's Disease | Insomnia

Canada
Assistance Publique - Hôpitaux de Paris
Novartis

Completed

Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations (SUFEMYO)

Sickle Cell Disease | Thalassemia | Myelodysplasia

France
Children's Hospital Medical Center, Cincinnati

Completed

Randomized Study of Pergolide in Children With Tourette Syndrome

Tourette Syndrome
UCB Pharma

Completed

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

IDIOPATHIC PARKINSON'S DISEASE

Germany
NYU Langone Health
Tourette Association of America

Completed

Omega-3 Fatty Acids in Tourette's Disorder

Tourette's Disorder

United States
National University of Malaysia

Completed

Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease

Response to Levodopa | Motor Outcomes | Quality of Life Outcomes

Malaysia
Yale University
Edison Pharmaceuticals Inc; Rembrandt Foundation

Completed

Open-Trial of EPI-743 for Adults With Tourette Syndrome

Tourette Syndrome

United States
University of California, San Francisco
Novartis

Completed

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems

Parkinsons Disease With Dementia | Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Cancer

United States
Rio de Janeiro State University

Completed

Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension

Obstructive Sleep Apnea | Secondary Hypertension

Brazil
Jay F. Piccirillo, MD
Barnes-Jewish Hospital; Washington University Siteman Cancer Center

Completed

Chemotherapy-Induced Cognitive Impairment (CICI)

Cognitive Symptoms

United States
Shenzhen Beike Bio-Technology Co., Ltd.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Unknown

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica

Progressive Multiple Sclerosis | Neuromyelitis Optica.

China
Daiichi Sankyo Co., Ltd.

Completed

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria

Japan, China
Catalysis SL

Completed

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Cirrhosis | Chronic Hepatitis C

Cuba
National Center for Research Resources (NCRR)
Yale University

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder

Tourette Syndrome
National Center for Research Resources (NCRR)
University of Rochester

Completed

Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome

Tourette Syndrome
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Classic Hodgkin Lymphoma | Lymphocyte-Rich Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage I Mixed Cellularity... and other conditions

United States
Dana-Farber Cancer Institute
Karyopharm Therapeutics Inc; William Lawrence and Blanche Hughes Foundation

Active, not recruiting

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Relapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditions

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

Anaplastic Large Cell Lymphoma, ALK-Positive | Hepatosplenic T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-Negative | Stage II Angioimmunoblastic T-cell Lymphoma | Stage II Enteropathy-Associated T-Cell Lymphoma | Stage III Angioimmunoblastic... and other conditions

United States
Christopher Dvorak

No longer available

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Acute Myeloid Leukemia | Leukocyte Disorders | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Cytopenias | Immune Deficiency | Lymphomas | Bone Marrow Failure | Osteopetrosis | Hemoglobinopathy | Anemia Due to Intrinsic Red Cell Abnormality

United States
Celldex Therapeutics

Terminated

A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

Chronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chronic Myelogenous Leukemia (CML) | Non-Hodgkins Lymphoma (NHL) | For Donors | Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling | For Recipients and other conditions

United States
National Cancer Institute (NCI)

Completed

Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

Anaplastic Large Cell Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Adult Nasal Type Extranodal NK/T-Cell Lymphoma

United States, Canada
National Cancer Institute (NCI)

Completed

Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Recurrent Adult Lymphoblastic Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent... and other conditions

United States
Beth Christian
Genentech, Inc.; Celgene

Active, not recruiting

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditions

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Acute Lymphoblastic Leukemia | Down Syndrome | Philadelphia Chromosome Positive | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia | Adult B Lymphoblastic Lymphoma | Ann Arbor Stage I B Lymphoblastic Lymphoma | Ann Arbor Stage... and other conditions

United States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia | Childhood Acute Myeloid Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 and other conditions

United States
National Cancer Institute (NCI)

Completed

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

B-cell Adult Acute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell... and other conditions

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Juvenile Myelomonocytic Leukemia | Childhood Acute Myeloid Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous Leukemia | Childhood Myelodysplastic Syndromes | Chronic Phase Chronic Myelogenous Leukemia | Previously Treated Myelodysplastic... and other conditions

United States
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Chronic Lymphocytic Leukemia (CLL) | Cutaneous T-cell Lymphoma (CTCL) | Mycosis Fungoides (MF) | Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype | Adult T-Cell Leukemia/Lymphoma (ATLL)

United States

Clinical Trials on Carcinomas/Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations